Clonal expansion may account for high levels of quinolone resistance in Salmonella enterica serovar enteritidis

Applied and Environmental Microbiology

Volumn 71, Issue 5, 2005, Pages 2587-2591

  Kilmartin, Donna ^a   Morris, D ^a   O'Hare, C ^a   Corbett Feeney, G ^a   Cormican, M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID RESISTANCE; AMINO ACIDS; ELECTROPHORESIS;

MUTATIONS; NALIDIXIC ACID; QUINOLONE;

BACTERIOPHAGES;

CIPROFLOXACIN; NALIDIXIC ACID; QUINOLONE;

ANTIBIOTICS; CLONAL GROWTH; TOLERANCE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOPHAGE TYPING; CLONAL VARIATION; CONTROLLED STUDY; INCIDENCE; IRELAND; MICROBIAL DIVERSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SEROTYPE;

DNA GYRASE; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; POINT MUTATION; SALMONELLA ENTERITIDIS;

EASTERN HEMISPHERE; EURASIA; EUROPE; IRELAND; WESTERN EUROPE; WORLD;

ENTERITIDIS; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS;

EID: 18444419148     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.71.5.2587-2591.2005     Document Type: Article

References (16)

1. Aarestrup, F. M., C. Wiuff, K. Molbak, and E. J. Threlfall. 2003. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47:827-829.
2. Centers for Disease Control and Prevention. 2001. Standardized molecular subtyping of foodborne bacterial pathogens by pulse-field gel electrophoresis. Centers for Disease Control and Prevention, Atlanta, Ga.
3. Hakanen, A., P. Kotilainen, J. Jalava, A. Siitonen, and P. Huovinen. 1999. Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. J. Clin. Microbiol. 37:3572-3577.
4. Herikstad, H., P. Hayes, M. Mokhtar, M. L. Fracaro, E. J. Threlfall, and F. J. Angulo. 1997. Emerging quinolone-resistant salmonella in the United States. Emerg. Infect. Dis. 3:371-372.
5. Kilmartin, D. M., D. Morris, M. Glennon, G. Corbett-Feeney, and M. G. Cormican. 2003. Rapid detection of common mutations in the quinolone resistance determining region (QRDR) of the gyrA gene of Salmonella enterica. Abstr. Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-100. American Society for Microbiology, Washington, D.C.
6. McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. Wilson. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.
7. Molbak, K., P. Gerner-Smidt, and H. C. Wegener. 2002. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg. Infect. Dis. 8:514-515.
8. NCCLS. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria the grow aerobically. Approved standard M7-A5, 5th ed., vol. 20. NCCLS, Wayne, Pa.
9. O'Hare, C., G. Doran, N. Delappe, D. Morris, V. Buckley, P. McKeown, W. Anderson, and M. G. Cormican. 2004. Antimicrobial resistance and phage types of human and non-human Salmonella enterica isolates from 1998-2003. Commun. Dis. Public Health 7:193-199.
10. Qiang, Y. Z., T. Qin, W. Fu, W. P. Cheng, Y. S. Li, and G. Yi. 2002. Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 49:549-552.
11. Snyder, L., and W. Champness. 1997. Molecular genetics of bacteria, vol. 1. ASM Press, Washington, D.C.
12. Soto, S. M., M. A. Gonzalez-Hevia, and M. C. Mendoza. 2003. Antimicrobial resistance in clinical isolates of Salmonella enterica serotype Enteritidis: relationships between mutations conferring quinolone resistance, integrons, plasmids, and genetic types. J. Antimicrob. Chemother. 51:1287-1291.
13. Stock, I., and B. Wiedemann. 2000. Natural antibiotic susceptibility of Salmonella enterica strains. Int. J. Antimicrob. Agents 16:211-217.
14. Walker, R. A., N. Saunders, A. J. Lawson, E. A. Lindsay, M. Dassama, L. R. Ward, M. J. Woodward, R. H. Davies, E. Liebana, and E. J. Threlfall. 2001. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J. Clin. Microbiol. 39:1443-1448.
15. Wiuff, C., M. Madsen, D. L. Baggesen, and F. M. Aarestrup. 2000. Quinolone resistance among Salmonella enterica from cattle, broilers, and swine in Denmark. Microb. Drug Resist. 6:11-17.
16. Younmans, G. P., P. Y. Paterson, and H. M. Sommers. 1985. The biological and clinical basis of infectious disease. The W. B. Saunders Co., Philadelphia, Pa.